GSK Stock: GSK plc Stock Price, Analysis & Insights
Get live GSK stock price $51.17, comprehensive GSK plc stock analysis, charts, news, and expert forecast. Real-time GSK stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known ...
Company Information
- CEO
- Luke Victor Miels
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 68629
Contact Information
- Website
- https://www.gsk.com
- Address
- 980 Great West Road
- Country
- GB
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 102.9 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 13.5)
✓ Lower volatility stock (Beta: 0.29) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for GSK plc shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for GSK plc
- ⚠Investors should consider how GSK plc fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
102.91B
P/E Ratio (TTM)
13.50
Beta
0.29
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare GSK with peer companies:
- Price
- $55.60
- Market cap
- 113.54B
- Price
- $0.11
- Market cap
- 224.63M
- Price
- $295.76
- Market cap
- 78.24B
- Price
- $98.04
- Market cap
- 125.09B
- Price
- $404.50
- Market cap
- 87.84B
- Price
- $373.06
- Market cap
- 82.76B
- Price
- $790.29
- Market cap
- 95.00B
- Price
- $43.57
- Market cap
- 104.75B
- Price
- $435.49
- Market cap
- 110.53B
- Price
- $81.29
- Market cap
- 34.08B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.